Pharma Bio Services Elects New Director at Annual Meeting

Pharma Bio Services ( (PBSV) ) has issued an announcement.

On May 15, 2025, Pharma-Bio Serv, Inc. held its 2025 Annual Meeting of Stockholders where Howard Spindel was elected as a Class III director until the 2028 Annual Meeting. The selection of Crowe PR PSC as the Company’s independent certified public accountants for the fiscal year ending October 31, 2025, was ratified. Additionally, a non-binding advisory vote determined that the compensation of the named executive officers will be reviewed every three years.

Spark’s Take on PBSV Stock

According to Spark, TipRanks’ AI Analyst, PBSV is a Neutral.

Pharma Bio Services is experiencing significant financial challenges with declining revenue and weak cash flows despite a strong balance sheet. The technical indicators suggest a bearish trend, and the valuation is unattractive with a negative P/E ratio. The overall outlook remains cautious, with a need for improvement in financial performance to enhance investor confidence.

To see Spark’s full report on PBSV stock, click here.

More about Pharma Bio Services

Average Trading Volume: 5,684

Technical Sentiment Signal: Strong Sell

Current Market Cap: $9.86M

For a thorough assessment of PBSV stock, go to TipRanks’ Stock Analysis page.